fatty diacid comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2025-11-05. Numbers and descriptions here follow the published literature rather than marketing material.
Identity and purity are usually established with reversed-phase high-performance liquid chromatography for the main peak and with mass spectrometry for the observed molecular mass. Peptide mapping after enzymatic digestion confirms the primary sequence, while amino acid analysis provides a quantitative composition check. Size-exclusion chromatography and ion-exchange chromatography are used to look for aggregates and charge variants. Water content, residual solvents, and counter-ion content are measured separately, since a lyophilised powder is often reported on an as-is basis unless a correction is applied.
Research-grade material circulates through suppliers that differ widely in documentation and testing practice, so a certificate of analysis is a starting point rather than proof of quality. Independent verification typically repeats chromatographic purity and mass confirmation on the received lot, and compares results against a retained reference standard. Regulatory status varies by jurisdiction, and a substance cleared as a medicine is not interchangeable with a research chemical of the same name. Open questions include how closely non-pharmaceutical lots match approved material in impurity profile and in aggregate content.
Solid tirzepatide is handled as a lyophilised, hygroscopic peptide powder that should be kept desiccated, protected from light, and stored frozen, typically at or below minus twenty degrees Celsius for long-term retention. Material left at ambient temperature for extended periods can take up moisture, which promotes aggregation and deamidation. Commercial liquid presentations are kept refrigerated between two and eight degrees Celsius and are not frozen. Reconstituted laboratory solutions are generally held cold and used within a short window because hydrolysis and oxidation continue slowly in solution.
Tirzepatide is a synthetic peptide built from 39 amino acid residues. Its sequence is related to human glucose-dependent insulinotropic polypeptide, with modifications that include a C-terminal extension and a C20 fatty diacid joined through a linker. Those changes raise the molecule's affinity for serum albumin, which slows renal filtration and lengthens the time it stays in circulation. The free base has an average molecular mass near 4813.5 daltons. The compound is made by solid-phase peptide synthesis followed by chromatographic purification.
At the receptor level, tirzepatide activates both the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. Both belong to the class B family of G protein-coupled receptors and signal largely through cyclic AMP accumulation. The compound binds the two receptors with differing affinity, and the pattern of signaling at each site is described in the literature as biased rather than simply proportional to occupancy. Tissues carrying these receptors include pancreatic islets, adipose tissue, the central nervous system, and the gastrointestinal tract. The relative weight of each receptor population in producing metabolic effects continues to be studied.
Published work supports the view that engaging two incretin receptors produces changes in glucose handling and body weight larger than those seen with single-receptor activation. Why that difference arises is not fully settled. Open questions include how much of the observed weight effect depends on central versus peripheral signaling, and whether the two receptors form interacting complexes. Most reported findings come from controlled trials and animal models, and translation between species is imperfect. Further research is expected to refine these points over time.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Lyophilised solid, may form a loose cake |
| Solubility class | Soluble in water | Practically insoluble in nonpolar solvents |
| Storage temperature, solid | -20 °C or below | Desiccated and protected from light |
| Storage temperature, liquid | 2-8 °C | Refrigerated, not frozen |
| Typical identity method | LC-MS | Observed mass compared with calculated mass |
Tirzepatide is a synthetic peptide that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. The molecule contains 39 amino acids and features a C20 fatty diacid moiety attached via a linker, which promotes albumin binding and extends its circulating half-life. Its sequence incorporates non-natural amino acids and modifications that reduce susceptibility to degradation by dipeptidyl peptidase-4. This dual receptor activity distinguishes it from selective GLP-1 receptor agonists.
The GIP receptor is expressed in pancreatic islets, adipose tissue, and the central nervous system, while GLP-1 receptors are found in pancreatic islets, the gastrointestinal tract, and the brain. Activation of both receptors can enhance glucose-dependent insulin secretion and reduce glucagon release. The relative contribution of each receptor to the overall pharmacological effect remains an area of ongoing investigation. Preclinical studies suggest that GIP receptor agonism may modulate appetite and energy balance, but the precise mechanisms in humans are not fully established.
In clinical research, tirzepatide has been studied in randomized controlled trials for glycemic control and body weight reduction. These trials typically measure changes in hemoglobin A1c and body weight over periods of several months. The drug is administered by subcutaneous injection, and its pharmacokinetic profile supports once-weekly dosing. Post-marketing surveillance continues to evaluate long-term outcomes and rare adverse events.
Peptide-based pharmaceutical products such as tirzepatide require controlled temperature management to preserve structural integrity. Manufacturer labeling generally specifies refrigeration at 2 to 8 degrees Celsius before first use, with protection from light and freezing. Exposure to repeated temperature cycling can promote aggregation or deamidation, which alters the analytical profile even when the visible solution appears unchanged. Once a product is in use, the permitted storage window and temperature range are defined by the specific labeled presentation rather than by general peptide rules.
Identity and purity assessment of tirzepatide relies primarily on reversed-phase high-performance liquid chromatography coupled with ultraviolet detection. Mass spectrometry, often in electrospray ionization mode, confirms the molecular mass and detects sequence-related impurities. Peptide mapping after enzymatic digestion provides residue-level confirmation of the backbone. Each method addresses a different question: chromatography for purity and related substances, mass measurement for identity, and mapping for sequence fidelity. No single technique covers all three.
Recommended storage for reference material is a freezer at approximately -20 degrees Celsius, protected from light and moisture. Commercial injectable presentations are stored refrigerated between 2 and 8 degrees Celsius and must not be frozen. Product labelling generally permits a limited period at controlled room temperature once dispensed, with the exact window depending on the presentation. Repeated temperature cycling is avoided because it can promote aggregation or deamidation of the peptide chain.
Identity and purity are assessed by reversed-phase high-performance liquid chromatography, with mass confirmation by electrospray ionisation mass spectrometry. Peptide mapping after enzymatic digestion verifies the primary sequence. Size-exclusion chromatography quantifies aggregates, while circular dichroism provides a secondary-structure fingerprint. Bioanalytical quantification in plasma uses immunoassay or LC-MS/MS. Reported purity for research-grade lots is commonly 95 percent or higher, and residual water content is checked by Karl Fischer titration.
A protein subunit is a polypeptide chain or protein molecule that assembles (or "coassembles") with other protein molecules to form a protein complex. Large assemblies of proteins such as viruses often use a small number of types of protein subunits as building blocks. A key step in creating a recombinant protein vaccine is the identification and isolation of a protein subunit from the pathogen which is likely to trigger a strong and effective immune response, without including the parts of the virus or bacterium that enable the pathogen to reproduce. Parts of the protein shell or capsid of a virus are often suitable. The goal is for the protein subunit to prime the immune system response by mimicking the appearance but not the action of the pathogen. Another protein-based approach involves self‐assembly of multiple protein subunits into a virus-like particle (VLP) or nanoparticle. The purpose of increasing the vaccine's surface similarity to a whole virus particle (but not its ability to spread) is to trigger a stronger immune response. Protein subunit vaccines are generally made through protein production, manipulating the gene expression of an organism so that it expresses large amounts of a recombinant gene. A variety of approaches can be used for development depending on the vaccine involved. Yeast, baculovirus, or mammalian cell cultures can be used to produce large amounts of proteins in vitro. Protein-based vaccines are being used for hepatitis B and for human papillomavirus (HPV).
Using these design principles, proteins can either be released to, or sequestered from, their native environment, allowing condensates to serve as a tool to alter the biochemical activity of specific proteins with a high level of control.
== ISO 4500 - ISO 4999 == ISO 4548 Methods of test for full-flow lubricating oil filters for internal combustion engines ISO 4548-7:2012 Part 7: Vibration fatigue test ISO 4551:1987 Ferroalloys – Sampling and sieve analysis ISO 4552 Ferroalloys – Sampling and sample preparation for chemical analysis ISO 4552-1:1987 Part 1: Ferrochromium, ferrosilicochromium, ferrosilicon, ferrosilicomanganese, ferromanganese ISO 4552-2:1987 Part 2: Ferrotitanium, ferromolybdenum, ferrotungsten, ferroniobium, ferrovanadium ISO 4570 Tyre valve threads ISO 4578 Adhesives — Determination of peel resistance of high-strength adhesive bonds — Floating-roller method ISO 4582 Plastics — Determination of changes in colour and variations in properties after exposure to daylight under glass, natural weathering or laboratory light sources ISO 4587 Adhesives — Determination of tensile lap-shear strength of rigid-to-rigid bonded assemblies ISO 4618:2014 Paints and varnishes – Terms and definitions ISO 4628 Paints and varnishes – Evaluation of degradation of coatings – Designation of quantity and size of defects, and of intensity of uniform changes in appearance ISO 4628-1 General introduction and designation system ISO 4628-2 Assessment of degree of blistering ISO 4628-3 Assessment of degree of rusting ISO 4628-4 Assessment of degree of cracking ISO 4628-5 Assessment of degree of flaking ISO 4628-6 Assessment of degree of chalking by tape method ISO 4628-7 Assessment of degree of chalking by velvet method ISO 4628-8 Assessment of degree of delamination and corrosion around a scribe ISO 4628-10 Assessment of degree of filiform corrosion ISO 4648:1991 Rubber, vulcanized or thermoplastic — Determination of dimensions of test pieces and products for test purposes [Withdrawn: replaced with ISO 23529] ISO 4661 Rubber, vulcanized — Preparation of samples and test pieces ISO 4661-1:1993 Rubber, vulcanized or thermoplastic — Preparation of samples and test pieces — Part 1: Physical tests [Withdrawn: replaced with ISO 23529] ISO 4661-2:2018 Rubber, vulcanized — Preparation of samples and test pieces — Part 2: Chemical tests ISO 4683 Raw sheep skins ISO 4683-1:1998 Part 1: Descriptions of defects ISO 4720:2009 Essential oils – Nomenclature ISO 4730:2017 Essential oil of Melaleuca, terpinen-4-ol type (Tea Tree oil) ISO 4786:1977 Enclosed-scale adjustable-range thermometers [Withdrawn without replacement] ISO 4787:2010 Laboratory glassware – Volumetric instruments – Methods for testing of capacity and for use ISO 4788:2005 Laboratory glassware – Graduated measuring cylinders ISO 4791 Laboratory apparatus – Vocabulary relating to apparatus made essentially from glass, porcelain or vitreous silica ISO 4791-1:1985 Part 1: Names for items of apparatus ISO 4795:1996 Glass for thermometer bulbs ISO 4801:1979 Glass alcoholometers and alcohol hydrometers not incorporating a thermometer ISO 4805:1982 Laboratory glassware – Thermo-alcoholometers and alcohol-thermohydrometers ISO 4824:1993 Dentistry — Ceramic denture teeth [Withdrawn: replaced with ISO 22112] ISO 4831:2006 Microbiology of food and animal feeding stuffs – Horizontal method for the detection and enumeration of coliforms – Most probable number technique ISO 4832:2006 Microbiology of food and animal feeding stuffs – Horizontal method for the enumeration of coliforms – Colony-count technique ISO 4833 Microbiology of the food chain – Horizontal method for the enumeration of microorganisms ISO 4833-1:2013 Part 1: Colony count at 30 degrees C by the pour plate technique ISO 4833-2:2013 Part 2: Colony count at 30 degrees C by the surface plating technique ISO 4848:1980 Concrete — Determination of air content of freshly mixed concrete — Pressure method [Withdrawn: replaced with ISO 1920-2] ISO 4858:1982 Wood — Determination of volumetric shrinkage [Withdrawn: replaced with ISO 13061-14] ISO 4859:1982 Wood — Determination of radial and tangential swelling [Withdrawn: replaced with ISO 13061-15] ISO 4860:1982 Wood — Determination of volumetric swelling [Withdrawn: replaced with ISO 13061-16] ISO 4866:2010 Mechanical vibration and shock – Vibration of fixed structures – Guidelines for the measurement of vibrations and evaluation of their effects on structures ISO 4871:1996 Acoustics – Declaration and verification of noise emission values of machinery and equipment ISO/IEC 4873:1991 Information technology – ISO 8-bit code for information interchange – Structure and rules for implementation ISO 4875 Metal-cutting band saw blades ISO 4875-1:2006 Part 1: Vocabulary ISO 4880:1997 Burning behaviour of textiles and textile products – Vocabulary ISO 4882:1979 Office machines and data processing equipment – Line spacings and character spacings ISO 4885:2017 Ferrous materials – Heat treatments – Vocabulary ISO 4892 Plastics – Methods of exposure to laboratory light sources ISO 4902:1989 Information technology – Data communication – 37-pole DTE/DCE interface connector and contact number assignments ISO 4903:1989 Information technology – Data communication – 15-pole DTE/DCE interface connector and contact number assignments ISO/IEC 4909:2006 Identification cards – Financial transaction cards – Magnetic stripe data content for track 3 ISO 4921:2000 Knitting – Basic concepts – Vocabulary ISO/IEC 4922-1 Information security — Secure multiparty computation ISO/IEC 4922-1:2023 Part 1: General ISO 4977 Double cold-reduced electrolytic tinplate ISO 4977-1:1984 Part 1: Sheet [Withdrawn: replaced with ISO 11949] ISO 4977-2:1984 Part 2: Coil for subsequent cutting into sheets [Withdrawn: replaced with ISO 11949]
Sources: en.wikipedia.org
Rubin estimated that it was used to do 200 million vaccinations per year during the last years of the campaign. Those closely involved in the campaign were awarded the "Order of the Bifurcated Needle". This, a personal initiative by Donald Henderson, was a lapel badge, designed and made by his daughter, formed from the needle shaped to form an "O". This represented "Target Zero", the objective of the campaign.
H2O2 + H2R → 2H2O + R The exact mechanism of this reaction is not known. Any heavy metal ion (such as copper cations in copper(II) sulfate) can act as a noncompetitive inhibitor of catalase. However, "Copper deficiency can lead to a reduction in catalase activity in tissues, such as heart and liver." Furthermore, the poison cyanide is a noncompetitive inhibitor of catalase at high concentrations of hydrogen peroxide. Arsenate acts as an activator. Three-dimensional protein structures of the peroxidated catalase intermediates are available at the Protein Data Bank.
=== Plants, climate and environmental change === Plant responses to climate and other environmental changes can inform one's understanding of how these changes affect ecosystem function and productivity. For example, plant phenology can be a useful proxy for temperature in historical climatology, and the biological impact of climate change and global warming. Palynology, the analysis of fossil pollen deposits in sediments from thousands or millions of years ago allows the reconstruction of past climates. Estimates of atmospheric CO2 concentrations since the Palaeozoic have been obtained from stomatal densities and the leaf shapes and sizes of ancient land plants. Ozone depletion can expose plants to higher levels of ultraviolet radiation-B (UV-B), resulting in lower growth rates. Moreover, information from studies of community ecology, plant systematics, and taxonomy is essential to understanding vegetation change, habitat destruction and species extinction.
Sources: en.wikipedia.org
It is normally kept frozen, desiccated, and away from light, with brief warming to room temperature before opening to limit condensation. Repeated freeze-thaw cycles are avoided because they stress the peptide. Once in solution, the material is held cold and used promptly.
Mass spectrometry gives the observed molecular mass, which is compared with the calculated value for the expected sequence. Reversed-phase chromatography shows retention behaviour and main peak purity. Peptide mapping adds sequence-level confirmation when the question requires it.
Typical entries include appearance, chromatographic purity as area percent, observed mass, water or residual solvent content, and the analytical methods used. The document reflects the lot tested and the laboratory that performed the work. It does not by itself establish that the delivered vial matches the tested lot.
It is a synthetic peptide and a dual agonist of two incretin receptors. It is not a small molecule, and it is not structurally related to the older single-receptor peptide agonists.